This suggests that the EGFR plays an important role in cutaneous defense by its crucial role to mediate the expression of AMP such as RNase 7 and may offer an explanation for the increased susceptibility for skin infections of cancer patients receiving anti-EGFR therapy (32). This evidence concerns the gene EGFR and skin infection.